Management of Opioid-Induced Constipation in Patients on Suboxone
Introduction to Guideline Recommendations
- The National Comprehensive Cancer Network (NCCN) guidelines recommend against the use of docusate for managing opioid-induced constipation, as it has not shown significant benefit 1
First-Line Therapy for Opioid-Induced Constipation
- The NCCN guidelines suggest starting with a stimulant laxative, such as senna 8.6-17.2 mg daily, as prophylaxis when initiating Suboxone 2, 3
- Bisacodyl 10-15 mg daily is also recommended as a first-line option, with the goal of achieving 1 non-forced bowel movement every 1-2 days 4, 5
Second-Line Options for Opioid-Induced Constipation
- If stimulant laxatives are insufficient, adding an osmotic laxative such as polyethylene glycol (PEG) 17 g daily is recommended, as it is the most cost-effective option 2, 3
- Lactulose 30-60 mL BID-QID and magnesium hydroxide 30-60 mL daily-BID are also recommended as second-line options 4, 5
Peripherally Acting Mu-Opioid Receptor Antagonists for Refractory Constipation
- Methylnaltrexone 0.15 mg/kg subcutaneously every other day (maximum once daily) is recommended for refractory cases, as it works on gastrointestinal receptors without reducing opioid-mediated analgesia 4, 5, 6
- Naldemedine is also recommended as an FDA-approved alternative 1